International Society for the Study of Women's Sexual Health

Role of Biotechnology and Pharmaceutical Companies in Developing Novel Therapies for Female Sexual Dysfunction

Female sexual disorders have historically been treated with multiple non-medical and off-label medical therapies by a limited number of experienced clinicians. Yet, most therapies have insufficient clinical evidence to support their safety and efficacy. Thus, the development of safe and effective therapies for the treatment of sexual disorders in women is critical to improving the overall management of these conditions, and increasing access to care. The International Society for the Study of Women’s Sexual Health (ISSWSH) supports the role of biotechnology and pharmaceutical companies, and other investigators developing novel therapies for female sexual dysfunction. ISSWSH rejects a “one size fits all” approach to treating female sexual dysfunction due to the multiplicity of biopsychosocial factors that impact sexual health. The concept of personalized medicine, and the availability of multiple therapeutic options are critical in this field.

Save the Date

ISSWSH Fall Course 2019
November 14-16, 2019   118 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH Annual Meeting 2020
March 5-8, 2020   230 days left
Renaissance Orlando at Seaworld, Orlando, FL, USA

ISSWSH Annual Meeting 2021
March 4-7, 2021   594 days left
Renaissance Dallas Hotel, Dallas, TX, USA

Latest Tweets

New data from OMGyes. Help your patients learn about #orgasm. https://t.co/d8BeXI5jTt https://t.co/H45JkN6qTC ISSWSH
A new  article discusses changes in sexuality in ovarian cancer survivors and their partners. https://t.co/I2KHu3KS9G #ovariancancer ISSWSH
Symptomatic POP is associated with female sexual dysfunction. Surgical intervention seems to have a positive impact… https://t.co/tJYjjVDad8 ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!